Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

被引：0
|
作者：
Schmidt, MK
van Sprundel, TC
Rookus, MA
Brohet, R
van Asperen, CJ
Rutgers, EJT
Tollenaar, RAEM
van't Veer, LJ
机构：
[1] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands
来源：
BREAST CANCER RESEARCH | 2005年 / 7卷 / Suppl 2期
关键词：
Breast Cancer; Contralateral Breast Cancer; BRCA2 Mutation Carrier; Mutation Testing; Contralateral Prophylactic Mastectomy;
D O I：
10.1186/bcr1096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [31] Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
    Lee, Y. C.
    Milne, R. L.
    Lheureux, S.
    Friedlander, M.
    McLachlan, S. A.
    Martin, K. L.
    Bernardini, M. Q.
    Smith, C.
    Picken, S.
    Nesci, S.
    Hopper, J. L.
    Phillips, K. A.
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 114 - 120
  • [32] Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers
    Singer, Christian F.
    BREAST CARE, 2021, 16 (02) : 144 - 148
  • [33] The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers Implications for Counseling
    Vencken, Peggy M. L. H.
    Kriege, Mieke
    Hooning, Maartje
    Menke-Pluymers, Marian B.
    Heemskerk-Gerritsen, Bernadette A. M.
    van Doorn, Lena C.
    Collee, Margriet M.
    Jager, Agnes
    van Montfort, Cees
    Burger, Curt W.
    Seynaeve, Caroline
    CANCER, 2013, 119 (05) : 955 - 962
  • [34] Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
    KA Phillips
    RL Milne
    MA Rookus
    D Goldgar
    M Friedlander
    SA McLachlan
    S Buys
    AC Antoniou
    K Birch
    MB Terry
    DF Easton
    P Weideman
    M Daly
    N Andrieu
    EM John
    MJ Hooning
    IL Andrulis
    T Caldes
    H Olsson
    JL Hopper
    Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
  • [35] Bilateral Risk-Reduction Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Meta-analysis
    Francesca De Felice
    Claudia Marchetti
    Angela Musella
    Innocenza Palaia
    Giorgia Perniola
    Daniela Musio
    Ludovico Muzii
    Vincenzo Tombolini
    Pierluigi Benedetti Panici
    Annals of Surgical Oncology, 2015, 22 : 2876 - 2880
  • [36] Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers
    Laitman, Yael
    Boker, Lital Keinan
    Liphsitz, Irena
    Weissglas-Volkov, Daphna
    Litz-Philipsborn, Shira
    Schayek, Hagit
    Friedman, Eitan
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 631 - 635
  • [37] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Leonardo Salmena
    Henry T Lynch
    Charmaine Kim-Sing
    William D Foulkes
    Parviz Ghadirian
    Susan L Neuhausen
    Rochelle Demsky
    Nadine Tung
    Peter Ainsworth
    Leigha Senter
    Andrea Eisen
    Charis Eng
    Christian Singer
    Ophira Ginsburg
    Joanne Blum
    Tomasz Huzarski
    Aletta Poll
    Ping Sun
    Steven A Narod
    Breast Cancer Research, 14
  • [38] BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials
    Levy-Lahad, E
    Krieger, M
    Gottfeld, O
    Renbaum, P
    Klein, G
    Eisenberg, S
    Lahad, A
    Kaufman, B
    Catane, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, : 13 - 18
  • [39] Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
    Im, Kate M.
    Kirchhoff, Tomas
    Wang, Xianshu
    Green, Todd
    Chow, Clement Y.
    Vijai, Joseph
    Korn, Joshua
    Gaudet, Mia M.
    Fredericksen, Zachary
    Pankratz, V. Shane
    Guiducci, Candace
    Crenshaw, Andrew
    McGuffog, Lesley
    Kartsonaki, Christiana
    Morrison, Jonathan
    Healey, Sue
    Sinilnikova, Olga M.
    Mai, Phuong L.
    Greene, Mark H.
    Piedmonte, Marion
    Rubinstein, Wendy S.
    Hogervorst, Frans B.
    Rookus, Matti A.
    Collee, J. Margriet
    Hoogerbrugge, Nicoline
    van Asperen, Christi J.
    Meijers-Heijboer, Hanne E. J.
    van Roozendaal, Cees E.
    Caldes, Trinidad
    Perez-Segura, Pedro
    Jakubowska, Anna
    Lubinski, Jan
    Huzarski, Tomasz
    Blecharz, Pawel
    Nevanlinna, Heli
    Aittomaki, Kristiina
    Lazaro, Conxi
    Blanco, Ignacio
    Barkardottir, Rosa B.
    Montagna, Marco
    D'Andrea, Emma
    Devilee, Peter
    Olopade, Olufunmilayo I.
    Neuhausen, Susan L.
    Peissel, Bernard
    Bonanni, Bernardo
    Peterlongo, Paolo
    Singer, Christian F.
    Rennert, Gad
    Lejbkowicz, Flavio
    HUMAN GENETICS, 2011, 130 (05) : 685 - 699
  • [40] Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Timothy R Rebbeck
    Susan M Domchek
    Breast Cancer Research, 10
12345